If you’ve been researching ketamine therapy in Sandy, UT for depression, you’ve probably run into two names that sound almost interchangeable: Spravato and IV ketamine. They’re closely related, they work on the same receptor system, and they can both help people who haven’t responded to traditional antidepressants. But they are not the same treatment and the differences matter when you’re deciding which path fits your diagnosis, your insurance, and your life. At Nervana Medical, we offer ketamine-based mental health care as part of an integrative practice, so we walk through this comparison with patients often. Here’s the honest version.
Spravato and ketamine are related, not identical
Ketamine is a racemic molecule, which means it’s a 50/50 mix of two mirror-image forms: R-ketamine and S-ketamine. Spravato is purified S-ketamine its generic name is esketamine delivered as a nasal spray. IV ketamine is the full racemic molecule delivered into a vein.
That’s the chemistry. The practical difference is bigger than the molecule. Spravato is an FDA-approved psychiatric medication with a specific, regulated treatment pathway. IV ketamine for depression is used off-label the drug is FDA-approved as an anesthetic, and clinicians have decades of evidence supporting its use for mood disorders, but that particular use hasn’t gone through the FDA’s depression-specific approval process. Neither approach is “better” by default. They’re built for different situations.
What Spravato is approved for
Spravato (esketamine) is FDA-approved for two groups of adults:
- Treatment-resistant depression: major depression that hasn’t responded to at least two oral antidepressants.
- Major depressive disorder with acute suicidal ideation or behavior: where rapid symptom relief is the goal.
In January 2025, the FDA approved Spravato as the first and only standalone monotherapy for treatment-resistant depression. Before that, it had to be prescribed alongside an oral antidepressant. Now it can be used either on its own or in combination, depending on what your provider recommends. That approval was a meaningful shift, because it gave people who couldn’t tolerate oral antidepressants a real option.
How the two treatments actually differ
The clinical headline is similar; both can lift depression quickly, often within hours to days rather than the weeks oral antidepressants take. Where they diverge is in delivery, dosing, oversight, and cost.
Route and dosing. Spravato is intranasal only, given at fixed doses of 56 mg or 84 mg. IV ketamine is infused and dosed by body weight, commonly starting around 0.5 mg/kg for depression, which gives the provider more room to individualize. See our other blog: https://www.nervanamedical.com/dissociation-does-not-equal-efficacy/
Oversight. Because of the risk of sedation, dissociation, and transient spikes in blood pressure, Spravato can only be given in a certified healthcare setting through the Spravato REMS program. Every patient is monitored for at least two hours after each dose, can’t drive until the next day after a full night’s sleep, and needs someone to take them home. IV ketamine sessions also require monitoring, but the structure is set by the clinic rather than a federal risk-management program.
Cost and insurance. This is often the deciding factor. Because Spravato is FDA-approved for depression, it is frequently covered by insurance with prior authorization. IV ketamine for depression is typically self-pay, since insurers rarely reimburse off-label use.
How to think about which one fits
There’s no universal winner, but a few patterns hold true. Spravato tends to make sense when you carry a formal diagnosis of treatment-resistant depression, when insurance coverage matters to your budget, and when a standardized, FDA-regulated pathway gives you peace of mind. IV ketamine tends to make sense when a provider wants to tailor the dose precisely, when your situation falls outside Spravato’s specific indications, or when you’ve tried intranasal treatment and want a different delivery route.
What shouldn’t get lost in the comparison is the part that surrounds the medication. Ketamine, in either form, works best inside real psychiatric care: an accurate diagnosis, attention to the rest of your health, and a plan for what happens between sessions. That whole-person framing is the reason we treat mental health alongside hormones, metabolic health, and aesthetics under one roof as an integrative med spa in Utah, rather than running ketamine as a standalone service. Depression rarely exists in isolation, and neither should its treatment.
A note on safety and honesty
Both treatments carry real considerations; dissociation during the session, short-term blood pressure changes, and the need for monitored administration. They are not at-home remedies, and they aren’t right for everyone. A thorough consultation comes first: your history, your current medications, your goals, and a frank conversation about what the evidence does and doesn’t support. If another approach fits you better, we’ll tell you.
The bottom line
Spravato and IV ketamine are close cousins, not twins. Spravato is FDA-approved, insurance-friendly, fixed-dose, and tightly regulated; IV ketamine is off-label, usually self-pay, and more individualized. The right choice depends on your diagnosis, your coverage, and a careful clinical conversation which is exactly where treatment should start.
Frequently Asked Questions
Is Spravato the same as ketamine?
Not quite. Spravato is purified S-ketamine (esketamine) given as a nasal spray, while IV ketamine is the full racemic molecule given through a vein. They’re chemically related and work on the same receptor system, but they differ in FDA status, dosing, oversight, and insurance coverage.
Does insurance cover Spravato or IV ketamine?
Spravato is FDA-approved for treatment-resistant depression, so it’s often covered with prior authorization. IV ketamine for depression is used off-label and is usually self-pay, since most insurers don’t reimburse it. Coverage always depends on your specific plan.
How long do I have to stay after a Spravato treatment?
At least two hours. Spravato is given through the FDA’s REMS program, which requires monitored observation after each dose. You also can’t drive until the next day after a restful night’s sleep, so you’ll need a ride home.
Can Spravato be used without an antidepressant?
Yes. As of January 2025, the FDA approved Spravato as a standalone monotherapy for treatment-resistant depression. It can be used on its own or alongside an oral antidepressant, depending on your provider’s recommendation.
Which is better for treatment-resistant depression?
Neither is universally better. Spravato has FDA approval and insurance pathways specific to treatment-resistant depression; IV ketamine offers more dosing flexibility but is off-label and self-pay. The right fit depends on your diagnosis, budget, and a clinical evaluation.
Book a Ketamine Therapy Consultation in Sandy, UT
If you’re weighing Spravato against IV ketamine, the best next step is a real conversation; not a sales pitch. Our team offers ketamine therapy in Sandy, UT as part of a whole-person approach to mental health, and we’re happy to help you understand which path actually fits your situation. Book a consultation and we’ll take it from there.